MONECO Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
MONECO Advisors's GILD Position: Q2 2026 in Review
MONECO Advisors increased its Gilead Sciences (GILD) stake by 7.1% in Q2 2026, buying an estimated $33.5K and bringing the position to 3,822 shares worth $483K. The position accounts for 0.03% of the portfolio, ranked #372.
MONECO Advisors first reported a position in GILD in Q2 2020 and has held it in 19 quarters since. The position peaked at $599K in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- MONECO Advisors held 3,822 shares of Gilead Sciences worth $483K as of Q2 2026.
- MONECO Advisors bought 254 Gilead Sciences shares in Q2 2026, an estimated $33.5K.
- Gilead Sciences made up 0.03% of MONECO Advisors's portfolio in Q2 2026, its #372 holding.
- MONECO Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 19 quarters since.
- MONECO Advisors's Gilead Sciences position peaked at $599K in Q1 2025.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on MONECO Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.